Edmond De Rothschild Holding S.A. Mirati Therapeutics, Inc. Transaction History

Edmond De Rothschild Holding S.A.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$36.54 - $54.26 $548,100 - $813,900	15,000 Added 8.87%	184,060 $6.84 Million
Q4 2022 Feb 09, 2023	BUY	$41.27 - $98.62 $412,700 - $986,200	10,000 Added 6.29%	169,060 $7.66 Million
Q2 2022 Aug 12, 2022	BUY	$39.16 - $88.71 $234,959 - $532,260	6,000 Added 3.92%	159,060 $10.7 Million
Q1 2022 May 10, 2022	BUY	$75.82 - $150.97 $4.78 Million - $9.52 Million	63,060 Added 70.07%	153,060 $12.6 Million
Q4 2021 Feb 10, 2022	BUY	$132.01 - $190.29 $763,017 - $1.1 Million	5,780 Added 6.86%	90,000 $13.2 Million
Q3 2021 Nov 12, 2021	BUY	$132.13 - $177.45 $1.84 Million - $2.48 Million	13,960 Added 19.87%	84,220 $14.9 Million
Q2 2021 Aug 11, 2021	BUY	$144.0 - $179.73 $3.15 Million - $3.94 Million	21,900 Added 45.29%	70,260 $11.3 Million
Q1 2021 May 17, 2021	BUY	$158.92 - $221.61 $1.14 Million - $1.58 Million	7,150 Added 17.35%	48,360 $8.28 Million
Q4 2020 Feb 12, 2021	SELL	$162.05 - $240.27 $2.8 Million - $4.15 Million	-17,290 Reduced 29.56%	41,210 $9.05 Million
Q2 2020 Aug 07, 2020	BUY	$72.01 - $120.39 $2.38 Million - $3.97 Million	33,000 Added 129.41%	58,500 $6.68 Million
Q1 2020 May 15, 2020	BUY	$69.78 - $116.21 $1.78 Million - $2.96 Million	25,500 New	25,500 $1.96 Million

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.